Part 2085 - RESEARCH
- Section 2085.10 - Definitions
- Section 2085.15 - Eligibility
- Section 2085.20 - Authorization Procedure
- Section 2085.25 - Terms and Conditions of Authorization
- Section 2085.30 - Informed Consent
- Section 2085.35 - Research Order Blanks for Dispensing Delta-9-THC Capsules
- Section 2085.40 - Labeling Requirements
- Section 2085.45 - Packaging Requirements
- Section 2085.50 - Confidentiality of Cancer Chemotherapy Patients Receiving delta-9-THC Medication
- Section 2085.55 - Reports and Recordkeeping
- Section 2085.60 - Audits and Inspections
- Section 2085.65 - Security
- Exhibit A - DAS Form 229-1
- Exhibit B - DASA Form 229-2
- Exhibit C - Special Instructions overing Research Medication Order Forms for Delta-9-Tetrahydrocannabinol
- Exhibit D - Special Instructions Covering Research Medication Labels for Delta-9-Tetrahydrocannabinol Containers
- Exhibit E - Research Order for Delta-9-Tetrahydrocannabinol